Thane, India

Satish Shamlal Patil

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Thane, IN (2021)
  • Tamil Nadu, IN (2023 - 2024)

Company Filing History:


Years Active: 2021-2024

Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Inventor Spotlight: Satish Shamlal Patil from Thane, India**

Introduction

Satish Shamlal Patil is an accomplished inventor based in Thane, India. With a notable portfolio of five patents, he has made significant contributions to the pharmaceutical field, particularly in the development of compounds for smoking cessation.

Latest Patents

Among his most recent innovations is the patent for a varenicline compound and the process of manufacturing it. This invention focuses on synthesizing substantially pure varenicline and its intermediates. Furthermore, it encompasses the pharmaceutical compositions containing varenicline and outlines methods for their use in aiding individuals to quit smoking. The implications of this work are substantial, as it aids in public health efforts to reduce smoking rates.

Career Highlights

Satish currently works with Par Pharmaceutical, Inc., a notable entity in the pharmaceutical industry. Throughout his career, he has dedicated himself to advancing the field through innovative solutions, demonstrating a strong commitment to improving health outcomes with his inventions.

Collaborations

Satish has collaborated with several talented individuals at work, including Joseph Prabahar Koilpillai and Sayuj Nath. Together, they aim to push the boundaries of pharmaceutical innovation, enhancing both product efficacy and patient care.

Conclusion

Satish Shamlal Patil's work represents a significant step forward in the fight against smoking addiction. His dedication to developing effective pharmaceutical solutions showcases the importance of innovation in improving public health. His contributions are sure to leave a lasting impact in the pharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…